Revolution Medicines Inc —— 财务报表 (NASDAQ:RVMD) | MetaTrader

展开完整图表

新闻

Revolution Medicines: "Strong Buy" On Daraxonrasib Win And Expansions Underway (RVMD)

Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today (NYSE:JNJ)

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

Stocks Settle Higher in Hopes for an Agreement to End the Iran War

Revolution Medicines Soars on Phase 3 Trial Results. Is It Too Late to Buy?

Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)

Stocks Recover as Oracle Leads Software Companies Higher

Stocks Retreat as US Set to Blockade the Strait of Hormuz

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.

Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?

Harbor Health Care ETF Q4 2025 Portfolio Review